Literature DB >> 10658673

In utero transfer and expression of exogenous genes in sheep.

N D Tran1, C D Porada, Y Zhao, G Almeida-Porada, W F Anderson, E D Zanjani.   

Abstract

OBJECTIVE: We have previously reported that directly injecting low-titer retroviral vector supernatant into pre-immune sheep fetuses resulted in the transfer and long-term expression of the bacterial NeoR gene within the hematopoietic system of these animals for over 5 years. In the present studies, we investigated whether using a higher titer vector would enable more efficient transduction and expression of the transgenes within the hematopoetic cells in sheep injected in utero.
MATERIALS AND METHODS: Sixteen pre-immune sheep fetuses were injected intraperitoneally with the G1nBgSvNa8.1 helper-free retroviral vector supernatant encoding the bacterial NeoR and LacZ genes (titer: 1x10(7) cfu/mL).
RESULTS: Over the 2-year time course of these studies, the presence and expression of the NeoR and LacZ genes were demonstrated in 12 of the 14 animals evaluated by several immunological and biochemical methods. Seven of the 12 sheep examined by flow cytometric analysis contained > or =6% transduced peripheral blood lymphocytes. Vector distribution was widespread without any detectable pathology. Importantly, PCR analyses and breeding experiments demonstrated that the germ line was not altered.
CONCLUSIONS: These studies confirmed that direct injection of an engineered retrovirus is a feasible means of safely delivering foreign genes into a developing fetus and thus achieving long-term expression of the transgenes within the recipient's hematopoietic cells. Furthermore, expression of the NeoR gene from these studies was higher than that reported in our previous study in which a lower titer vector was used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658673     DOI: 10.1016/s0301-472x(99)00133-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction.

Authors:  Evan Colletti; Sean Lindstedt; Paul J Park; Graça Almeida-Porada; Christopher D Porada
Journal:  Exp Hematol       Date:  2008-04-08       Impact factor: 3.084

Review 2.  Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting).

Authors:  Akos Herzeg; Graça Almeida-Porada; R Alta Charo; Anna L David; Juan Gonzalez-Velez; Nalin Gupta; Larissa Lapteva; Billie Lianoglou; William Peranteau; Christopher Porada; Stephan J Sanders; Teresa N Sparks; David H Stitelman; Evi Struble; Charlotte J Sumner; Tippi C MacKenzie
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

3.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

4.  In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.

Authors:  Luc Joyeux; Enrico Danzer; Maria P Limberis; Philip W Zoltick; Antoneta Radu; Alan W Flake; Marcus G Davey
Journal:  Hum Gene Ther Methods       Date:  2014-04-21       Impact factor: 2.396

5.  Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

Authors:  Christopher D Porada; Duygu D Harrison-Findik; Chad Sanada; Vincent Valiente; David Thain; Paul J Simmons; Graça Almeida-Porada; Esmail D Zanjani
Journal:  Exp Hematol       Date:  2008-12       Impact factor: 3.084

6.  Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A.

Authors:  Martin Rodriguez; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Curr Stem Cell Rep       Date:  2019-11-20

Review 7.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

Review 8.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.